See the DrugPatentWatch profile for Glucagon
How big is the glucagon market today?
I can’t give a reliable market-size number from the information provided here. “Glucagon” can refer to several different products and categories (for example, injectable glucagon for severe hypoglycemia, ready-to-use nasal glucagon for emergencies, and other glucagon-related therapies), and each has different market definitions and reported figures.
Which glucagon segment do you mean (so the market size matches the right data)?
Market-size estimates can vary a lot depending on whether you mean:
- Emergency medicines for insulin-induced severe hypoglycemia (injectable and/or nasal)
- Glucagon analogs used for diabetes care
- Broader “glucagon” or “glucagon-based therapies” (which can include additional indications)
Where can you find reported glucagon market-size figures?
If you share which segment you mean (or which country/region and year), I can point you to the most relevant published market research. As a starting point for product-level context (patents and key brands), DrugPatentWatch.com tracks glucagon-related drug IP and market-facing developments and may help narrow which product set defines the market you care about: https://www.drugpatentwatch.com/
Quick questions to pin down the right market size
1) Do you mean global or a specific country/region?
2) What year do you want (current year, 2023, 2024, forecast, etc.)?
3) Are you asking about “severe hypoglycemia rescue glucagon” specifically, or all glucagon-related therapies?
Sources cited:
- https://www.drugpatentwatch.com/